About Protolabs
Protolabs is the world's fastest digital manufacturing source for rapid prototyping and on-demand production. The technology-enabled company produces custom parts and assemblies in as fast as one day with automated 3D printing, CNC machining, sheet metal fabrication, and injection molding processes. Its digital approach to manufacturing enables accelerated time to market, reduces development and production costs, and minimizes risk throughout the product life cycle. Visit protolabs.com for more information.
Forward-Looking Statements
Statements contained in this press release regarding matters that are not historical or current facts are “forward-looking statements” within the meaning of The Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties and other factors which may cause the results of Protolabs to be materially different than those expressed or implied in such statements. Certain of these risk factors and others are described in the “Risk Factors” section within reports filed with the SEC. Other unknown or unpredictable factors also could have material adverse effects on Protolabs’ future results. The forward-looking statements included in this press release are made only as of the date hereof. Protolabs cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, Protolabs expressly disclaims any intent or obligation to update any forward-looking statements to reflect subsequent events or circumstances.
Proto Labs, Inc. | ||||||||
Condensed Consolidated Balance Sheets | ||||||||
(In thousands) | ||||||||
March 31, | December 31, | |||||||
2018 | 2017 | |||||||
(Unaudited) | ||||||||
Assets | ||||||||
Current assets | ||||||||
Cash and cash equivalents | $ | 45,095 | $ | 36,707 | ||||
Short-term marketable securities | 53,467 | 57,424 | ||||||
Accounts receivable, net | 58,464 | 51,503 | ||||||
Inventory | 9,506 | 11,271 | ||||||
Income taxes receivable | - | 1,832 | ||||||
Other current assets | 8,106 | 6,267 | ||||||
Total current assets | 174,638 | 165,004 | ||||||
Property and equipment, net | 187,863 | 166,440 | ||||||
Long-term marketable securities | 30,667 | 37,034 | ||||||
Goodwill | 128,752 | 128,504 | ||||||
Other intangible assets, net | 19,319 | 19,084 | ||||||
Other long-term assets | 2,670 | 2,672 | ||||||
Total assets | $ | 543,909 | $ | 518,738 | ||||
Liabilities and shareholders' equity | ||||||||
Current liabilities | ||||||||
Accounts payable | $ | 18,358 | $ | 15,876 | ||||
Accrued compensation | 9,736 | 12,100 | ||||||
Accrued liabilities and other | 10,809 | 8,408 | ||||||
Short-term debt obligations | - | 5,000 | ||||||
Income taxes payable | 2,962 | 2,371 | ||||||
Total current liabilities | 41,865 | 43,755 | ||||||
Long-term income taxes payable | 2,181 | 2,181 | ||||||
Long-term deferred tax liabilities | 7,582 | 6,966 | ||||||
Other long-term liabilities | 4,605 | 4,621 | ||||||
Shareholders' equity | 487,676 | 461,215 | ||||||
Total liabilities and shareholders' equity | $ | 543,909 | $ | 518,738 | ||||
Proto Labs, Inc. | ||||||||
Condensed Consolidated Statements of Operations | ||||||||
(In thousands, except share and per share amounts) | ||||||||
(Unaudited) | ||||||||
Three Months Ended | ||||||||
March 31, | ||||||||
2018 |
2017 |
|||||||
Revenue | ||||||||
Injection Molding | $ | 51,343 | $ | 47,916 | ||||
CNC Machining | 36,731 | 21,972 | ||||||
3D Printing | 12,325 | 10,085 | ||||||
Sheet Metal | 6,241 | - | ||||||
Other | 1,105 | 194 | ||||||
Total revenue | 107,745 | 80,167 | ||||||
Cost of revenue | 49,837 | 34,894 | ||||||
Gross profit | 57,908 | 45,273 | ||||||
Operating expenses | ||||||||
Marketing and sales | 16,572 | 12,987 | ||||||
Research and development | 6,665 | 5,823 | ||||||
General and administrative | 12,943 | 8,781 | ||||||
Total operating expenses | 36,180 | 27,591 | ||||||
Income from operations | 21,728 | 17,682 | ||||||
Other income, net | 178 | 315 | ||||||
Income before income taxes | 21,906 | 17,997 | ||||||
Provision for income taxes | 3,855 | 5,797 | ||||||
Net income | $ | 18,051 | $ | 12,200 | ||||
Net income per share: | ||||||||
Basic | $ | 0.67 | $ | 0.46 | ||||
Diluted | $ | 0.66 | $ | 0.46 | ||||
Shares used to compute net income per share: | ||||||||
Basic | 26,879,388 | 26,466,731 | ||||||
Diluted | 27,197,099 | 26,599,200 | ||||||
Proto Labs, Inc. | ||||||||||
Condensed Consolidated Statements of Cash Flows | ||||||||||
(In thousands) | ||||||||||
(Unaudited) | ||||||||||
Three Months Ended | ||||||||||
March 31, | ||||||||||
2018 | 2017 | |||||||||
Operating activities | ||||||||||
Net income | $ | 18,051 | $ | 12,200 | ||||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||
Depreciation and amortization | 6,259 | 4,250 | ||||||||
Stock-based compensation expense | 2,307 | 1,716 | ||||||||
Deferred taxes | 612 | 394 | ||||||||
Amortization of held-to-maturity securities | 163 | 301 | ||||||||
Other | 106 | (56 | ) | |||||||
Changes in operating assets and liabilities | (1,353 | ) | (13 | ) | ||||||
Net cash provided by operating activities | 26,145 | 18,792 | ||||||||
Investing activities | ||||||||||
Purchases of property and equipment | (25,513 | ) | (7,812 | ) | ||||||
Cash used for acquisitions, net of cash acquired | (90 | ) | - | |||||||
Purchases of marketable securities | (3,389 | ) | (16,520 | ) | ||||||
Proceeds from maturities of marketable securities | 13,551 | 10,755 | ||||||||
Net cash used in investing activities | (15,441 | ) | (13,577 | ) | ||||||
Financing activities | ||||||||||
Payments on debt | (5,000 | ) | - | |||||||
Proceeds from exercises of stock options and other | 2,252 | 194 | ||||||||
Repurchases of common stock | - | (2,662 | ) | |||||||
Net cash used in financing activities | (2,748 | ) | (2,468 | ) | ||||||
Effect of exchange rate changes on cash and cash equivalents | 432 | 346 | ||||||||
Net increase in cash and cash equivalents | 8,388 | 3,093 | ||||||||
Cash and cash equivalents, beginning of period | 36,707 | 68,795 | ||||||||
Cash and cash equivalents, end of period | $ | 45,095 | $ | 71,888 | ||||||
Proto Labs, Inc. | ||||||||||
Reconciliation of GAAP to Non-GAAP Net Income per Share | ||||||||||
(In thousands, except share and per share amounts) | ||||||||||
(Unaudited) | ||||||||||
Three Months Ended | ||||||||||
March 31, | ||||||||||
2018 |
2017 |
|||||||||
Non-GAAP net income, adjusted for stock-based compensation expense, amortization expense, and unrealized loss on foreign currency |
||||||||||
GAAP net income | $ | 18,051 | $ | 12,200 | ||||||
Add back: | ||||||||||
Stock-based compensation expense | 2,307 | 1,716 | ||||||||
Amortization expense | 764 | 163 | ||||||||
Unrealized loss on foreign currency | 156 | 63 | ||||||||
Total adjustments 1 | 3,227 | 1,942 | ||||||||
Income tax benefits on adjustments 2 | (2,043 | ) | (574 | ) | ||||||
Non-GAAP net income | $ | 19,235 | $ | 13,568 | ||||||
Non-GAAP net income per share: | ||||||||||
Basic | $ | 0.72 | $ | 0.51 | ||||||
Diluted | $ | 0.71 | $ | 0.51 | ||||||
Shares used to compute non-GAAP net income per share: | ||||||||||
Basic | 26,879,388 | 26,466,731 | ||||||||
Diluted | 27,197,099 | 26,599,200 | ||||||||
1 Stock-based compensation expense, amortization expense, and unrealized loss on foreign currency were included in the following GAAP consolidated statement of operations categories: | ||||||||||
Three Months Ended | ||||||||||
March 31, | ||||||||||
2018 |
2017 |
|||||||||
Cost of revenue | $ | 287 | $ | 197 | ||||||
Marketing and sales | 377 | 269 | ||||||||
Research and development | 314 | 222 | ||||||||
General and administrative | 2,093 | 1,191 | ||||||||
Total operating expenses | 2,784 | 1,682 | ||||||||
Other income, net | 156 | 63 | ||||||||
Total adjustments | $ | 3,227 | $ | 1,942 | ||||||
2 For the three months ended March 31, 2018 and 2017, income tax effects were calculated using the effective tax rate for the relevant jurisdictions. Our non-GAAP tax rates differ from our GAAP tax rates due primarily to the mix of activity incurred in domestic and foreign tax jurisdictions and removing effective tax rate benefits from stock-based compensation activity in the quarter. | ||||||||||
Proto Labs, Inc. | ||||||||||
Reconciliation of GAAP to Non-GAAP Operating Margin | ||||||||||
(In thousands) | ||||||||||
(Unaudited) | ||||||||||
Three Months Ended | ||||||||||
March 31, | ||||||||||
2018 |
2017 |
|||||||||
Revenue | $ | 107,745 | $ | 80,167 | ||||||
Income from operations | 21,728 | 17,682 | ||||||||
GAAP operating margin | 20.2 | % | 22.1 | % | ||||||
Add back: | ||||||||||
Stock-based compensation expense | 2,307 | 1,716 | ||||||||
Amortization expense | 764 | 163 | ||||||||
Total adjustments | 3,071 | 1,879 | ||||||||
Non-GAAP income from operations adjusted for stock-based compensation expense and amortization expense |
$ | 24,799 | $ | 19,561 | ||||||
Non-GAAP operating margin | 23.0 | % | 24.4 | % | ||||||
Proto Labs, Inc. | |||||||||||||||||||||||||
Comparison of GAAP to Non-GAAP Revenue Growth | |||||||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||||||
Three Months Ended
|
Three Months Ended
March 31, 2017 |
% |
% Change
Constant |
||||||||||||||||||||||
GAAP | Adjustments 1 | Non-GAAP | GAAP |
Change 2 |
Currencies 3 | ||||||||||||||||||||
Revenues | |||||||||||||||||||||||||
United States | $ | 84,167 | $ | - | $ | 84,167 | $ | 60,176 | 39.9 | % | 39.9 | % | |||||||||||||
Europe | 19,945 | (2,534 | ) | 17,411 | 16,999 | 17.3 | % | 2.4 | % | ||||||||||||||||
Japan | 3,633 | (176 | ) | 3,457 | 2,992 | 21.4 | % | 15.5 | % | ||||||||||||||||
Total Revenue | $ | 107,745 | $ | (2,710 | ) | $ | 105,035 | $ | 80,167 | 34.4 | % | 31.0 | % | ||||||||||||
1 Revenue growth for the three month period ended March 31, 2018 has been recalculated using 2017 foreign currency exchange rates in effect during comparable periods to provide information useful in evaluating the underlying business trends excluding the impact of changes in foreign currency exchange rates. | |||||||||||||||||||||||||
2 This column presents the percentage change from GAAP revenue growth for the three month period ended March 31, 2017 to GAAP revenue growth for the three month period ended March 31, 2018. | |||||||||||||||||||||||||
3 This column presents the percentage change from GAAP revenue growth for the three month period ended March 31, 2017 (calculated using the foreign currency exchange rates in effect during that period) to non-GAAP revenue growth for the three month period ended March 31, 2018 (as recalculated using 2017 foreign currency exchange rates in order to provide a constant currency comparison). | |||||||||||||||||||||||||
Proto Labs, Inc. | ||||||
Product Developer Information | ||||||
(Unaudited) | ||||||
Three Months Ended | ||||||
March 31, | ||||||
2018 | 2017 | |||||
Unique product developers and engineers served | 18,057 | 14,801 | ||||
Note: the information above includes unique product developers and engineers who purchased our 3D Printed products in the United States and Europe through our web-based customer interface. The information does not include 3D Printing, Injection Molding and Sheet Metal customers who do not utilize our web-based customer interface; these customers are principally related to our recent acquisitions. | ||||||